Home › NDC Lookup › RxCUI directory › RxCUI 797063

Omeprazole 2.5 MG Granules for Oral Suspension — RxCUI 797063

RxNorm drug concept · Semantic clinical drug
RxCUI 797063 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI797063
Official nameOmeprazole 2.5 MG Granules for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asomeprazole 2.5 MG Delayed Release Granules for Oral Suspension; omeprazole 2.5 MG (as omeprazole magnesium 2.8 MG) Delayed Release Granules for Oral Suspension
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)3,056 prescriptions · 19 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Omeprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Omeprazole turns down your stomach's acid production by blocking the pump that makes acid in the first place. Depending on why you're taking it, that can mean relief from heartburn...
  • What exactly is omeprazole supposed to do for me?
  • Take it about 30 minutes before a meal, ideally before breakfast. Taking it before eating gives it the best chance to be absorbed and ready to work when your stomach starts produci...
  • When should I take it — before or after eating?
📖 Read our full Omeprazole guide →

🕸️ Concept Web — How Omeprazole 2.5 MG Granules for Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Omeprazole 2.5 MG Granules for Oral Suspension RxCUI 797063

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Omeprazole 7646
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Prilosec 203345
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Omeprazole Granules for Oral Suspension 1855328
    • Omeprazole Granule Product 1855327
    • Omeprazole Oral Product 1161028
    • Omeprazole Granules for Oral Suspension [Prilosec] 1855332
    • Prilosec Granule Product 1855333
    • Prilosec Oral Product 1178238
    • Granules for Oral Suspension 1540454
    • Granule Product 1294708
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Omeprazole 2.5 MG SCDC · 1855326
  • Omeprazole Granules for Oral Suspension SCDF · 1855328
  • Omeprazole Granule Product SCDG · 1855327
  • Omeprazole Oral Product SCDG · 1161028

Brand-Name Concepts

  • Omeprazole 2.5 MG Granules for Oral Suspension [Prilosec] SBD · 797065
  • Omeprazole 2.5 MG [Prilosec] SBDC · 1855336
  • Omeprazole Granules for Oral Suspension [Prilosec] SBDF · 1855332
  • Prilosec Granule Product SBDG · 1855333
  • Prilosec Oral Product SBDG · 1178238
  • Prilosec BN · 203345

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 797063 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
70515-0610-01 30 GRANULE, DELAYED RELEASE in 1 CARTON (70515-610-01) Prilosec Covis Pharma US, Inc 2017-08-25
70515-0625-01 30 GRANULE, DELAYED RELEASE in 1 CARTON (70515-625-01) Prilosec Covis Pharma US, Inc 2017-08-25
Observed labelers: Covis Pharma US, Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.